H. Cortés-Funes

Centre Hospitalier René-Dubos — France

Medicine · Health Sciences

50h-index14.2kcitations278works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Treatment and Pharmacology(82), Breast Cancer Treatment Studies(47), Lung Cancer Treatments and Mutations(41), HER2/EGFR in Cancer Research(38), Colorectal Cancer Treatments and Studies(35)

Publications278 total

Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancer
Journal of Clinical Oncology·2023· 32 cited
Topical heparin as an effective and safe treatment for patients with capecitabine-induced hand-foot syndrome: results of a phase IIA trial supported by proteomic profiling of skin biopsies
Therapeutic Advances in Medical Oncology·2022· 14 citedOpen Access
Uterine Leiomyoma with Lung Metastases Stump Tumour
Obstetrics and Gynaecology Cases - Reviews·2019Open Access
Mechanistic added value of a trans-Sulfonamide-Platinum-Complex in human melanoma cell lines and synergism with cis-Platin
Molecular Cancer·2017· 16 citedOpen Access
Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study.
PubMed·2015· 3 cited
Abstract 2575: Pharmacodynamic evaluation of the combination of carboplatin and paclitaxel associated with either pioglitazone or hydroxyurea, within a randomized phase 1 dose escalation clinical trial in patients with advanced solid tumors
Cancer Research·2015· 1 cited
Abstract 1539: Analysis of differential protein profiles in co-culture models of pancreatic cancer cells and fibroblasts
Cancer Research·2015
Final 10-year results of the Breast International Group 2–98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer
European Journal of Cancer·2015· 37 cited
High reduction of circulating tumor cells (CTCs) in patients with HER2-negative recurrent or metastatic breast cancer treated with eribulin as third-line therapy: ONSITE trial (OncoSur Analysis of the Treatment in Third Line of ABC with Eribulin)
Annals of Oncology·2015Open Access
Risk factors associated with Clostridium difficile infection in adult oncology patients
Supportive Care in Cancer·2014· 49 cited
Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer
Tumor Biology·2014· 9 cited
Relevance of insulin-like growth factor 1 receptor gene expression as a prognostic factor in non-small-cell lung cancer
Journal of Cancer Research and Clinical Oncology·2014· 19 citedOpen Access
Clinical experience with plerixafor as a mobilization regimen for autologous peripheral blood stem cell transplantation in patients with refractory germ cell tumors
Molecular and Clinical Oncology·2014· 10 citedOpen Access
A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial
The Breast·2014· 47 citedOpen Access
Trends in blood gene expression in non-small cell lung cancer patients treated with bevacizumab.
Journal of Clinical Oncology·2014
Systematic determination of EGFR mutation (m) and immunohistochemistry (IHC) of ALK translocation (t) status in patients (p) with newly non-small cell lung cancer (NSCLC).
Journal of Clinical Oncology·2014
<i> Clostridium difficile</i> infection in hospitalized cancer patients.
Journal of Clinical Oncology·2014
Head and neck cancer in the elderly: Survival and toxicity with biochemoradiation therapy.
Journal of Clinical Oncology·2014
Surgical therapy of lung metastases from colorectal carcinoma: A single institution retrospective study.
Journal of Clinical Oncology·2014
Pemetrexed (Pem) in combination with cisplatin (CP) or carboplatin (CB) for stage IV NSCLC: A single-institution experience.
Journal of Clinical Oncology·2014
page 1 of 14Next →

Frequent Co-authors

Ricardo Hitt(10), Rámón Colomer(9), Luis Paz‐Ares(8), Monica Castiglione‐Gertsch(6), Jurij Lindtner(5), Aron Goldhirsch(5), Manuel Hidalgo(5), Richard D. Gelber(4), Beat Thürlimann(4), Karen N. Price(4), Alan S. Coates(4), John Forbes(4), Edda Simoncini(4), M. López-Brea(4), Rocio García‐Carbonero(4), José Mayordomo(4), Daniel Castellano(4), Eva Ciruelos(4), José Trigo(3), Joan Carles(3)